Alzheimer's Society responds to the claim that amyloid-targeting drugs show no clinically meaningful positive effects.

Alzheimer's Society welcomes the decision and says the Government must be ambitious about preparing for new treatments.

CrossSense will help people with early-stage dementia with daily activities, such as making a cup of tea and interacting with loved ones.

Alzheimer’s Society supports and invests in innovations to transform the lives of people affected by dementia. This week, we were delighted to welcome new innovators to our award-winning innovation programme.  

Mother’s Day can be a joyful celebration for many, while for others it may be a difficult and emotionally complex day. Angelo Makri, our in-house dementia expert offers some tips for carers on relationships ahead of Mother's Day. 

Alzheimer's Society responds to the findings of a new study that suggests that a blood test could predict the risk of dementia in women up to 25 years before symptoms appear.